LAURUS LABS
|
The Current P/E Ratio of LAURUS LABS is 161.52.
Share Price | ₹586.6 | Feb 03,2025 |
Market Cap | ₹31,635.3 Cr | |
Earnings-TTM | ₹195.9 Cr | TTM-Consolidated Results |
Price/Earnings | 161.52x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of LAURUS LABS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹31,635.3 Cr] as on Feb 03,2025
(/) Earnings [ ₹195.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 161.52x ]
Thus, for LAURUS LABS , the investors are currently willing to pay 161.52 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LAURUS LABS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of LAURUS LABS over the last five years.
Historical PE (Price/Earnings) ratio chart of LAURUS LABS
PE Ratio Performance Analysis for LAURUS LABS
- LAURUS LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 42.96x.
- LAURUS LABS 's operated at median p/e ratio of 20.12x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LAURUS LABS 's p/e ratio peaked in Mar2024 at 133.9x.
- LAURUS LABS 's p/e ratio hit its five-year low in Mar2020 of 2.7x.
How does LAURUS LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
LAURUS LABS | 195.86 | 161.52 | 31,635.3 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.35 | 417,472.0 |
CIPLA LTD | 5,000.43 | 22.95 | 114,754.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.51 | 100,465.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.53 | 96,875.2 |
DIVIS LABORATORIES LTD | 2,067.00 | 75.64 | 156,342.0 |
MANKIND PHARMA LTD | 2,050.73 | 51.98 | 106,597.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 57.59 | 107,226.0 |
LUPIN LTD | 2,651.94 | 34.99 | 92,786.6 |
AUROBINDO PHARMA LTD | 3,598.83 | 18.19 | 65,453.4 |
ABBOTT INDIA LTD | 1,284.66 | 43.01 | 55,256.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LAURUS LABS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.19x |
Max industry PE | 161.52x |
Median industry PE | 36.35x |
Average industry PE | 49.39x |
You may also like the below Video Courses